eQcell Inc. Company Profile, Contacts & Intelligence

eQcell Inc. Overview

eQcell™ Inc. is Canada’s premier clinical-stage regenerative medicine company. Founded by Dr. Thomas Koch, Assistant Professor at Canada's University of Guelph, his work reflects 15 years of stem cell research and some $6 million of research investment. The company's target is regenerative therapies for human health utilizing the pathway of conditions and diseases affecting sporting and companion animals globally for which current treatments are ineffective, not fully effective, or palliative. eQcell has developed allogeneic equine cord blood stem cells, for which Dr. Koch published the world's first paper, and is producing canine adipose-derived mesenchymal stromal cells to provide novel therapeutic options. eQcell’s initial concentration in veterinary therapy is designed to most rapidly achieve marketing approval for its veterinary regenerative stem cells, in the process generating data leading to a scientifically and economically-effective pathway for translation into similar human applications. eQcell is a leader in the now-established science bridging development of therapeutics for both humans and animal health.

Headquarters

Guelph, Ontario, Ca

Website

www.eqcell.com

Industry

Biotechnology Research

Founded

2010

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

eQcell Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

eQcell Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

eQcell Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to eQcell Inc.

Explore companies in related markets and compare their industry and employee estimates.